serves as Chief Medical Officer and Deputy Director of the Joint Pathology Center (JPC) in Silver Spring, Maryland—formerly the Armed Forces Institute of Pathology. A molecular, genetic, and genitourinary pathologist, Dr. Moncur earned his MD from Dartmouth’s Geisel School of Medicine and both his MS and PhD from Dartmouth College.

Dr. Moncur previously served as Director of the Joint Pathology Center and as Chair of Pathology at Walter Reed National Military Medical Center. In 2020, he initiated the digital transformation of the JPC’s historic pathology repository—one of the nation’s largest—digitizing over 6 million glass slides and developing AI-ready datasets. His team’s work has supported prototype machine learning algorithms, including one that detects, grades, and predicts the prognosis of prostate cancer.

Dr. Moncur’s research spans molecular oncology and infectious diseases, with publications on the neuropathology of COVID-19, the pathology of measles as a re-emerging disease, and optimal testing for human papillomavirus in head and neck cancers.

Within the College of American Pathologists (CAP), Dr. Moncur serves on the Board of Governors, chairs the Council on Scientific Affairs, and is a member of both the Information Technology Leadership Committee and the Finance Committee. He previously chaired the CAP Molecular Oncology Committee and served as its advisor.

MLO August 2019 Preview

Related

Blood culture contamination in U.S. hospitals

Making ethical healthcare decisions: Exclusive interview with Dr. Sachin Jain

Trending

Inside the lab of 2026: Insights from 12 laboratory experts

Advancing laboratory excellence: An interview with the CAP’s Joel Todd Moncur, MD, PhD, MS, FCAP

Unmasking anti-nuclear antibodies: The critical role of serial dilution